Douglas Johnston - 16 Jun 2023 Form 4 Insider Report for LIPELLA PHARMACEUTICALS INC (LIPO)

Role
Chief Financial Officer
Signature
/s/ Douglas Johnston
Issuer symbol
LIPO
Transactions as of
16 Jun 2023
Net transactions value
$0
Form type
4
Filing time
21 Jun 2023, 16:52:24 UTC
Previous filing
20 Dec 2022
Next filing
19 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIPO Options to Purchase Award $0 +50,000 $0.000000 50,000 16 Jun 2023 Common Stock 50,000 $2.19 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.